Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinal Ganglion Cells | 7 | 2007 | 72 | 0.920 |
Why?
|
| Optic Nerve Diseases | 5 | 2004 | 31 | 0.720 |
Why?
|
| Vision Disorders | 6 | 2007 | 94 | 0.650 |
Why?
|
| Optic Atrophies, Hereditary | 4 | 2000 | 4 | 0.630 |
Why?
|
| Genetic Linkage | 6 | 2001 | 90 | 0.630 |
Why?
|
| X Chromosome | 4 | 2001 | 28 | 0.550 |
Why?
|
| Neurites | 2 | 2007 | 18 | 0.540 |
Why?
|
| Visual Fields | 6 | 2004 | 41 | 0.480 |
Why?
|
| Nystagmus, Pathologic | 3 | 1999 | 12 | 0.450 |
Why?
|
| Eye Diseases | 2 | 2003 | 38 | 0.410 |
Why?
|
| Optic Neuropathy, Ischemic | 4 | 2007 | 6 | 0.400 |
Why?
|
| Visual Acuity | 9 | 2003 | 236 | 0.350 |
Why?
|
| Point Mutation | 3 | 2000 | 97 | 0.340 |
Why?
|
| Optic Nerve | 6 | 2001 | 55 | 0.340 |
Why?
|
| Retinal Detachment | 3 | 1997 | 14 | 0.320 |
Why?
|
| DNA, Mitochondrial | 4 | 2005 | 84 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 1998 | 20 | 0.290 |
Why?
|
| Vitrectomy | 2 | 1997 | 21 | 0.280 |
Why?
|
| Nystagmus, Congenital | 2 | 2007 | 2 | 0.280 |
Why?
|
| Anthrax Vaccines | 2 | 2006 | 5 | 0.270 |
Why?
|
| Optic Neuritis | 2 | 2006 | 26 | 0.270 |
Why?
|
| Nerve Growth Factors | 1 | 2005 | 75 | 0.250 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 1 | 2005 | 2 | 0.250 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2005 | 43 | 0.250 |
Why?
|
| Toxins, Biological | 1 | 2004 | 23 | 0.240 |
Why?
|
| Eye Proteins | 1 | 2005 | 160 | 0.240 |
Why?
|
| Pupil Disorders | 2 | 2001 | 3 | 0.230 |
Why?
|
| Pedigree | 6 | 2001 | 159 | 0.230 |
Why?
|
| Blepharospasm | 1 | 2003 | 1 | 0.230 |
Why?
|
| Diabetic Retinopathy | 3 | 2009 | 110 | 0.230 |
Why?
|
| Cranial Nerve Diseases | 1 | 2003 | 14 | 0.230 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2005 | 786 | 0.230 |
Why?
|
| Serpins | 1 | 2005 | 205 | 0.220 |
Why?
|
| Pituitary Neoplasms | 2 | 2000 | 52 | 0.220 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2004 | 148 | 0.210 |
Why?
|
| Glucose | 1 | 2003 | 307 | 0.200 |
Why?
|
| Ophthalmology | 2 | 2000 | 39 | 0.190 |
Why?
|
| Neurology | 2 | 2000 | 43 | 0.190 |
Why?
|
| Neurocutaneous Syndromes | 1 | 2000 | 7 | 0.190 |
Why?
|
| Nerve Compression Syndromes | 1 | 2000 | 16 | 0.190 |
Why?
|
| Visual Pathways | 1 | 2000 | 31 | 0.190 |
Why?
|
| Humans | 35 | 2009 | 68618 | 0.180 |
Why?
|
| Molecular Biology | 2 | 1997 | 31 | 0.180 |
Why?
|
| Axons | 1 | 2001 | 139 | 0.180 |
Why?
|
| Vaccination | 1 | 2002 | 189 | 0.180 |
Why?
|
| Nervous System Diseases | 1 | 2000 | 142 | 0.170 |
Why?
|
| Adenoma | 1 | 2000 | 132 | 0.170 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 1293 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 1999 | 17 | 0.170 |
Why?
|
| Genetic Heterogeneity | 1 | 1999 | 11 | 0.170 |
Why?
|
| Nerve Fibers | 4 | 2005 | 77 | 0.160 |
Why?
|
| Eye Diseases, Hereditary | 1 | 1997 | 10 | 0.150 |
Why?
|
| Evoked Potentials, Visual | 1 | 1998 | 18 | 0.150 |
Why?
|
| Retina | 3 | 2009 | 252 | 0.150 |
Why?
|
| Pituitary Diseases | 1 | 1997 | 4 | 0.150 |
Why?
|
| Sella Turcica | 1 | 1997 | 10 | 0.150 |
Why?
|
| Adult | 14 | 2009 | 21403 | 0.140 |
Why?
|
| Retinal Diseases | 2 | 1995 | 40 | 0.140 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 1997 | 16 | 0.140 |
Why?
|
| Male | 20 | 2006 | 37321 | 0.140 |
Why?
|
| Acute Disease | 4 | 2005 | 658 | 0.140 |
Why?
|
| Genes, Dominant | 1 | 1996 | 51 | 0.140 |
Why?
|
| Scleral Buckling | 1 | 1996 | 1 | 0.140 |
Why?
|
| Diagnosis, Differential | 4 | 2007 | 1140 | 0.140 |
Why?
|
| Cataract Extraction | 1 | 1997 | 127 | 0.130 |
Why?
|
| Brain | 2 | 2003 | 2176 | 0.130 |
Why?
|
| Aged | 12 | 2003 | 14862 | 0.130 |
Why?
|
| Cell Separation | 2 | 2007 | 132 | 0.130 |
Why?
|
| Phacoemulsification | 1 | 1996 | 69 | 0.130 |
Why?
|
| Cell Culture Techniques | 2 | 2007 | 189 | 0.130 |
Why?
|
| Macular Edema | 3 | 2009 | 21 | 0.120 |
Why?
|
| Female | 17 | 2006 | 38074 | 0.120 |
Why?
|
| Alcohol Drinking | 1 | 2000 | 805 | 0.120 |
Why?
|
| Aged, 80 and over | 5 | 2003 | 4848 | 0.110 |
Why?
|
| Cell Count | 2 | 2005 | 248 | 0.110 |
Why?
|
| Visual Field Tests | 2 | 2003 | 8 | 0.110 |
Why?
|
| Smoking | 1 | 2000 | 1452 | 0.100 |
Why?
|
| Middle Aged | 12 | 2009 | 21147 | 0.100 |
Why?
|
| Multiple Sclerosis | 1 | 1994 | 132 | 0.100 |
Why?
|
| Chromosome Mapping | 3 | 2007 | 188 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2007 | 2083 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2009 | 219 | 0.090 |
Why?
|
| Lod Score | 2 | 2001 | 14 | 0.090 |
Why?
|
| Animals | 6 | 2009 | 20881 | 0.090 |
Why?
|
| Hyperglycemia | 2 | 2009 | 158 | 0.090 |
Why?
|
| Genotype | 2 | 2005 | 786 | 0.090 |
Why?
|
| Blindness | 2 | 2009 | 22 | 0.080 |
Why?
|
| Blood Glucose | 2 | 2009 | 631 | 0.080 |
Why?
|
| DNA | 2 | 2001 | 597 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 2 | 2001 | 492 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2003 | 3705 | 0.070 |
Why?
|
| Rats | 2 | 2007 | 5300 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 2009 | 183 | 0.070 |
Why?
|
| Genetic Markers | 2 | 1999 | 144 | 0.070 |
Why?
|
| Haplotypes | 2 | 1999 | 174 | 0.070 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2007 | 24 | 0.070 |
Why?
|
| Atrophy | 3 | 2000 | 112 | 0.070 |
Why?
|
| Staining and Labeling | 1 | 2007 | 144 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 1 | 2007 | 108 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2009 | 511 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2006 | 7277 | 0.070 |
Why?
|
| Thy-1 Antigens | 1 | 2005 | 4 | 0.070 |
Why?
|
| Tetracyclines | 1 | 2005 | 3 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2005 | 18 | 0.070 |
Why?
|
| Lac Operon | 1 | 2005 | 54 | 0.060 |
Why?
|
| beta-Galactosidase | 1 | 2005 | 88 | 0.060 |
Why?
|
| Doxycycline | 1 | 2005 | 49 | 0.060 |
Why?
|
| Risk | 1 | 2006 | 563 | 0.060 |
Why?
|
| Hemangiopericytoma | 1 | 2004 | 5 | 0.060 |
Why?
|
| Hemianopsia | 1 | 2004 | 8 | 0.060 |
Why?
|
| Horner Syndrome | 1 | 2004 | 8 | 0.060 |
Why?
|
| Ophthalmoplegia | 1 | 2004 | 20 | 0.060 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 226 | 0.060 |
Why?
|
| Tomography, Optical Coherence | 1 | 2005 | 88 | 0.060 |
Why?
|
| Ocular Motility Disorders | 1 | 2004 | 15 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2005 | 112 | 0.060 |
Why?
|
| Trans-Activators | 1 | 2005 | 237 | 0.060 |
Why?
|
| Efferent Pathways | 1 | 2003 | 15 | 0.060 |
Why?
|
| Brimonidine Tartrate | 1 | 2003 | 13 | 0.060 |
Why?
|
| Afferent Pathways | 1 | 2003 | 31 | 0.060 |
Why?
|
| Mutation | 2 | 2007 | 1213 | 0.060 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 40 | 0.060 |
Why?
|
| Orbital Pseudotumor | 1 | 2003 | 1 | 0.060 |
Why?
|
| Risk Factors | 3 | 2000 | 5731 | 0.060 |
Why?
|
| Recurrence | 2 | 1997 | 948 | 0.060 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2005 | 124 | 0.060 |
Why?
|
| Military Personnel | 1 | 2006 | 221 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2006 | 1553 | 0.060 |
Why?
|
| Diphosphonates | 1 | 2003 | 39 | 0.060 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2003 | 81 | 0.060 |
Why?
|
| Radiopharmaceuticals | 1 | 2003 | 114 | 0.060 |
Why?
|
| Quinoxalines | 1 | 2003 | 78 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 615 | 0.060 |
Why?
|
| Intraocular Pressure | 1 | 2003 | 143 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2004 | 2223 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2006 | 880 | 0.050 |
Why?
|
| Tacrolimus | 1 | 2004 | 127 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2007 | 617 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2003 | 100 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 1033 | 0.050 |
Why?
|
| Cell Survival | 1 | 2005 | 901 | 0.050 |
Why?
|
| Aspirin | 1 | 2003 | 295 | 0.050 |
Why?
|
| Ophthalmoscopy | 2 | 2001 | 13 | 0.050 |
Why?
|
| Microsatellite Repeats | 1 | 2001 | 40 | 0.050 |
Why?
|
| Adolescent | 3 | 2000 | 8912 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 649 | 0.050 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2001 | 19 | 0.050 |
Why?
|
| Exons | 1 | 2001 | 122 | 0.050 |
Why?
|
| Macaca mulatta | 1 | 2001 | 77 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 240 | 0.050 |
Why?
|
| Age of Onset | 1 | 2001 | 188 | 0.050 |
Why?
|
| DNA Primers | 1 | 2001 | 302 | 0.050 |
Why?
|
| Laser Therapy | 1 | 2001 | 54 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 2077 | 0.050 |
Why?
|
| Macula Lutea | 1 | 2001 | 6 | 0.050 |
Why?
|
| Retinal Artery Occlusion | 1 | 2001 | 7 | 0.050 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2001 | 24 | 0.050 |
Why?
|
| Heart Transplantation | 1 | 2004 | 328 | 0.050 |
Why?
|
| Child | 3 | 2001 | 6405 | 0.050 |
Why?
|
| Self Disclosure | 1 | 2000 | 55 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2004 | 371 | 0.050 |
Why?
|
| Decompression, Surgical | 1 | 2000 | 55 | 0.050 |
Why?
|
| Models, Animal | 1 | 2001 | 252 | 0.050 |
Why?
|
| Homocysteine | 1 | 2000 | 28 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2004 | 514 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2005 | 1330 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2003 | 234 | 0.040 |
Why?
|
| Kidd Blood-Group System | 1 | 1999 | 1 | 0.040 |
Why?
|
| Antihypertensive Agents | 1 | 2003 | 498 | 0.040 |
Why?
|
| Color Perception | 1 | 1999 | 9 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1999 | 56 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2000 | 714 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2005 | 2791 | 0.040 |
Why?
|
| Retinal Vessels | 2 | 2009 | 74 | 0.040 |
Why?
|
| Electronystagmography | 1 | 1998 | 2 | 0.040 |
Why?
|
| Eye Movements | 1 | 1998 | 44 | 0.040 |
Why?
|
| Electroretinography | 1 | 1998 | 122 | 0.040 |
Why?
|
| Prolactinoma | 1 | 1997 | 1 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2003 | 778 | 0.040 |
Why?
|
| Anemia, Sickle Cell | 1 | 2001 | 364 | 0.040 |
Why?
|
| United States | 3 | 2009 | 7367 | 0.040 |
Why?
|
| Retinal Perforations | 1 | 1996 | 1 | 0.030 |
Why?
|
| Vitreoretinopathy, Proliferative | 1 | 1996 | 2 | 0.030 |
Why?
|
| Scotoma | 1 | 1996 | 4 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 1996 | 9 | 0.030 |
Why?
|
| Genes, Recessive | 1 | 1996 | 18 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1996 | 18 | 0.030 |
Why?
|
| Glaucoma, Open-Angle | 1 | 1996 | 19 | 0.030 |
Why?
|
| Dexamethasone | 1 | 1997 | 150 | 0.030 |
Why?
|
| Trabeculectomy | 1 | 1996 | 5 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 1996 | 74 | 0.030 |
Why?
|
| Electron Probe Microanalysis | 1 | 1995 | 16 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2003 | 1070 | 0.030 |
Why?
|
| Ocular Hypertension | 1 | 1996 | 43 | 0.030 |
Why?
|
| Cataract | 1 | 1997 | 134 | 0.030 |
Why?
|
| Reoperation | 1 | 1997 | 467 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1995 | 351 | 0.030 |
Why?
|
| Disease Progression | 2 | 2009 | 1038 | 0.030 |
Why?
|
| Lenses, Intraocular | 1 | 1996 | 96 | 0.030 |
Why?
|
| Clinical Trials as Topic | 2 | 2009 | 848 | 0.030 |
Why?
|
| Uveitis, Posterior | 1 | 1994 | 1 | 0.030 |
Why?
|
| Phlebitis | 1 | 1994 | 4 | 0.030 |
Why?
|
| Retinal Vein | 1 | 1994 | 4 | 0.030 |
Why?
|
| Calcinosis | 1 | 1995 | 241 | 0.030 |
Why?
|
| Optic Disk | 1 | 1994 | 37 | 0.030 |
Why?
|
| Mice | 1 | 2005 | 8474 | 0.030 |
Why?
|
| Mitochondria | 1 | 1997 | 643 | 0.020 |
Why?
|
| Calcium | 1 | 1995 | 929 | 0.020 |
Why?
|
| Pregnancy | 1 | 1997 | 2334 | 0.020 |
Why?
|
| Child, Preschool | 1 | 1998 | 3187 | 0.020 |
Why?
|
| Inflammation | 1 | 1997 | 1030 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 1996 | 2455 | 0.020 |
Why?
|
| Infant | 1 | 1996 | 2891 | 0.020 |
Why?
|
| Ranibizumab | 1 | 2009 | 3 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 1996 | 3259 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2009 | 172 | 0.020 |
Why?
|
| Developing Countries | 1 | 2009 | 106 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2009 | 151 | 0.020 |
Why?
|
| Reference Values | 1 | 2009 | 579 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2009 | 328 | 0.020 |
Why?
|
| Smallpox Vaccine | 1 | 2006 | 2 | 0.020 |
Why?
|
| Hepatitis B Vaccines | 1 | 2006 | 11 | 0.020 |
Why?
|
| Influenza Vaccines | 1 | 2006 | 56 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 1997 | 7029 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 546 | 0.020 |
Why?
|
| Prednisone | 1 | 2003 | 104 | 0.010 |
Why?
|
| Logistic Models | 1 | 2006 | 1420 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 2550 | 0.010 |
Why?
|
| Albinism, Oculocutaneous | 1 | 2001 | 1 | 0.010 |
Why?
|
| Fundus Oculi | 1 | 2001 | 33 | 0.010 |
Why?
|
| Arterioles | 1 | 2001 | 40 | 0.010 |
Why?
|
| Fluorescein Angiography | 1 | 2001 | 57 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2004 | 458 | 0.010 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2000 | 12 | 0.010 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2000 | 39 | 0.010 |
Why?
|
| Retinal Hemorrhage | 1 | 2000 | 7 | 0.010 |
Why?
|
| Glycosaminoglycans | 1 | 2000 | 88 | 0.010 |
Why?
|
| Edema | 1 | 2000 | 66 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 2000 | 134 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 4655 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 5717 | 0.010 |
Why?
|
| Macrophages | 1 | 2000 | 647 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 2324 | 0.010 |
Why?
|